Vorobiof DA - Search Results

1

Mitoxantrone in the treatment of acute leukemia.

Vorobiof DA, Falkson G, Coccia-Portugal MA, Terblanche AP. Vorobiof DA, et al. Invest New Drugs. 1987 Dec;5(4):383-8. doi: 10.1007/BF00169980. Invest New Drugs. 1987. PMID: 3481364

2

Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.

Vorobiof DA, Terblanche AP, Falkson CI, Falkson G. Vorobiof DA, et al. Oncology. 1988;45(5):378-9. doi: 10.1159/000226645. Oncology. 1988. PMID: 3412747

3

Phase II study of high-dose 4'-epidoxorubicin in the treatment of advanced gastrointestinal cancer.

Vorobiof DA, Falkson G. Vorobiof DA, et al. Eur J Cancer Clin Oncol. 1989 Mar;25(3):563-4. doi: 10.1016/0277-5379(89)90271-x. Eur J Cancer Clin Oncol. 1989. PMID: 2703009 No abstract available.

4

Radionuclide angiographic monitoring in patients treated with potentially cardiotoxic cytostatic drugs.

Vorobiof DA, Falkson G, Iturralde MP. Vorobiof DA, et al. S Afr Med J. 1988 Sep 3;74(5):213-6. S Afr Med J. 1988. PMID: 3166211

5

Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.

Falkson G, Coccia-Portugal MA, Vorobiof DA, Terblanche AP, Dreyer R. Falkson G, et al. Among authors: vorobiof da. Am J Clin Oncol. 1986 Aug;9(4):311-4. Am J Clin Oncol. 1986. PMID: 3463190

6

Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.

Falkson G, Vorobiof DA. Falkson G, et al. Among authors: vorobiof da. Invest New Drugs. 1986;4(2):165-9. doi: 10.1007/BF00194597. Invest New Drugs. 1986. PMID: 3733376

7

Assessment of ventricular function by radionuclide angiography in patients receiving 4'-epidoxorubicin and mitoxantrone.

Vorobiof DA, Iturralde M, Falkson G. Vorobiof DA, et al. Cancer Chemother Pharmacol. 1985;15(3):253-7. doi: 10.1007/BF00263896. Cancer Chemother Pharmacol. 1985. PMID: 3863718

8

Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.

Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA. Alberts AS, et al. Among authors: vorobiof da. J Clin Oncol. 1988 Mar;6(3):527-35. doi: 10.1200/JCO.1988.6.3.527. J Clin Oncol. 1988. PMID: 3351560

9

Intranasal buserelin in the treatment of advanced prostatic cancer: a phase II trial.

Falkson G, Vorobiof DA. Falkson G, et al. Among authors: vorobiof da. J Clin Oncol. 1987 Sep;5(9):1419-23. doi: 10.1200/JCO.1987.5.9.1419. J Clin Oncol. 1987. PMID: 3114438

10

A phase II study of m-AMSA in patients with malignant mesothelioma.

Falkson G, Vorobiof DA, Lerner HJ. Falkson G, et al. Among authors: vorobiof da. Cancer Chemother Pharmacol. 1983;11(2):94-7. doi: 10.1007/BF00254253. Cancer Chemother Pharmacol. 1983. PMID: 6688764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters